October 2019
The Biocelect team was pleased to attend and exhibit at the Australian Military Medical Association (AMMA) 2019 Conference "after the WAR - Repatriation, Recovery & Public Health" at the Adelaide Convention Centre.
Click Here for More Information
September 2019
Members from the Biocelect team attend the 4th Annual Southern Cross Travel Medicine Conference(SCTMC 2019) in Sydney.
Click Here for More Information
30th June 2018
'Disease of poverty': Malaria 'back with a vengeance in
Australia's closest neighbours - Sydney Morning Herald 30th June 2018
August 2019
See Biocelect's attendance at the 2019 Healthed GP education days across Australia.
Click Here for More Information
September 2019
Members from the Biocelect team attend the 4th Annual Southern Cross Travel Medicine Conference(SCTMC 2019) in Sydney.
Click Here for More Information
August 2019
See Biocelect's attendance at the 2019 Healthed GP education days across Australia.
Click Here for More Information
20th July 2018
US FDA approves Krintafel (tafenoquine) for the radical cure of P. vivax malaria
2nd July 2018
Australia will lead efforts to eradicate malaria in the Indo-Pacific with a $300m strategy. (AAP)
26th July 2018
US FDA Advisory Committee votes in
favour of 60 Degrees Pharmaceuticals (60P) ARAKODA (tafenoquine) for the prevention of malaria
18th September 2018
Biocelect welcomes Australia's Therapeutic Goods Administration (TGA) approval of KODATEF (tafenoquine); the first malaria prevention drug approved in Australia in more than two decades
20th March 2019
60 Degrees Pharmaceuticals (60P) and its Australian distribution partner Biocelect Pty Ltd, began commercialising the new malaria prevention medicine, Kodatef® (tafenoquine succinate). The two organisations announced today that the first shipments of Kodatef have arrived and are now available to customers in Australia.